Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
The role of angiotensin converting enzyme gene polymorphism in pulmonary thromboembolism Source: Annual Congress 2004 - Pulmonary embolism Year: 2004
Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003
The effect of angiotension converting enzyme inhibitors on the production of TGF-β from fibroblast Source: Eur Respir J 2006; 28: Suppl. 50, 227s Year: 2006
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms Source: Eur Respir J 2001; 18: 1077 Year: 2001
Changes in the level of blood lactate in severely ill patients Source: Eur Respir J 2004; 24: Suppl. 48, 677s Year: 2004
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Diagnostic value of serum angiotensin converting enzyme in pulmonary sarcoidosis. A systematic review Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
Respiratory function changes in patients with coronary heart disease after long-term treatment course by β-blockers and angiotensin-converting enzyme inhibitors Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Correlation between the serum angiotensin converting enzyme (SACE) level and the bronchoalveolar lavage pattern in newly diagnosed pulmonary sarcoidosis stage 1 Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Source: Eur Respir J 2008; 31: 611-617 Year: 2008
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Source: Eur Respir J 2007; 29: 816-817 Year: 2007